课题基金 / 基金详情

项目摘要

项目成果

Zoltan P Arany的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Photoreceptor (PR) degeneration is a leading cause of blindness worldwide, and remains poorly understood. A leading cause of PR degeneration is thought to be damage instilled by reactive oxygen species (ROS). PRs are also some of the most highly metabolic cells in the body, and this high aerobic metabolism is a strong source of ROS. How PRs develop such high aerobic capacity, and how PRs balance this capacity with excess ROS, is not known. We propose here to test the hypotheses that 1) the dramatic developmental increase in PR mitochondrial metabolism seen during post-natal development is mediated by the transcriptional co-activators PGC- 1alpha and beta, known potent regulators of mitochondrial metabolism in other cells; and 2) PGC-1alpha and beta simultaneously regulate an anti-ROS program that can be usurped to slow PR degeneration. We will test these hypotheses with novel genetic mouse models, and with state-of-the-art approaches for gene delivery to the eye. Success in these studies may open new avenues for therapeutic intervention in these devastating diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acetate and Endothelial Pathobiology
  • 批准号:
    10736268
  • 项目类别:
  • 资助金额:
    $74.24万
  • 财政年份:
    2023
  • 负责人:
    Zoltan P Arany
  • 依托单位:
Comprehensive quantification of fuel use in cold-induced thermogenesis in vivo
  • 批准号:
    10637680
  • 项目类别:
  • 资助金额:
    $57.23万
  • 财政年份:
    2023
  • 负责人:
    Zoltan P Arany
  • 依托单位:
High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes
  • 批准号:
    10343859
  • 项目类别:
  • 资助金额:
    $65.58万
  • 财政年份:
    2021
  • 负责人:
    Zoltan P Arany
  • 依托单位:
High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes
  • 批准号:
    10331230
  • 项目类别:
  • 资助金额:
    $66.13万
  • 财政年份:
    2021
  • 负责人:
    Zoltan P Arany
  • 依托单位:
海外基金